Ceftazidime Powder For Solution Suppliers & Bulk Manufacturers

Available Forms: Powder for Solution

Available Strengths: 1 g, 2 g, 2.5 g, 3 g, 4 g

Reference Brands: Fortaz, Tazicef(US& EU)

Category: Antibiotics

Ceftazidime suspension inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, causing bacterial lysis. It is effective against gram-negative bacteria, including Pseudomonas aeruginosa. Benefits include targeted, reliable oral therapy for pediatric or outpatient infections, rapid bacterial clearance, broad-spectrum activity, and convenience in managing serious infections in children. Ceftazidime Powder for Solution is available in Powder for Solution and strengths such as 1 g, 2 g, 2.5 g, 3 g, 4 g. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ceftazidime Powder for Solution is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Ceftazidime Powder for Solution can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Ceftazidime suspension is approved in the EU and US for treating severe gram-negative bacterial infections, particularly in pediatric patients. In the EU, brands like Fortaz and generics are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on comprehensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, quality standards, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for ceftazidime suspension, ensuring adherence to European and US standards for safe, effective therapy in serious infections.